Invo Fertility, Inc. revenue
Invo Fertility, Inc.'s revenue was $6.8m in fiscal 2025, up 4.7% on the year before. Since fiscal 2011 ($71,503) it has grown at a compound 38.5% a year. Over the last twelve months it was $7.5m.
Revenue history
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 72 | 56 | 27 | 17 | 12 | 51 | 282 | 494 | 1,480 | 1,037 | 4,160 | 822 | 3,021 | 6,532 | 6,841 | 7,531 |
| Growth on the year before | — | −21.2% | −52.0% | −38.7% | −29.5% | +335.5% | +454.3% | +75.2% | +199.4% | −29.9% | +301.1% | −80.2% | +267.4% | +116.3% | +4.7% | — |
| Gross profit | 54 | 35 | 16 | 9 | 4 | 36 | 230 | 404 | 1,341 | 949 | 4,015 | 491 | 1,048 | 2,815 | 6,811 | — |
| Gross margin | 74.9% | 63.0% | 60.9% | 53.7% | 33.2% | 70.3% | 81.6% | 81.7% | 90.6% | 91.4% | 96.5% | 59.7% | 34.7% | 43.1% | 99.6% | — |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Fertility Clinic Services | $6.7M | 97.9% | ▲ 4.2% |
| Invocell Device | $147,193 | 2.1% | ▲ 33.1% |
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Revenue From External Customers | $6.8M | 99.6% | ▲ 4.7% |
| Clinic Revenue (part of Revenue From External Customers) | $6.7M | 98.2% | ▲ 4.2% |
| Products (part of Revenue From External Customers) | $120,193 | 1.8% | ▲ 47.4% |
| Inter Segment Revenue | $27,000 | 0.4% | ▼ 6.9% |
From Invo Fertility, Inc.'s 10-K filed June 2, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Invo Fertility, Inc. | $7.5m | 13.8% | 85.6% |
| Beyond Air, Inc. | $7.7m | 60.7% | 122.7% |
| Anbio Biotechnology | $8.6m | 5.6% | — |
| Nuwellis, Inc. | $9.0m | 8.4% | 2.8% |
| Milestone Scientific Inc. | $9.4m | 3.7% | -1.9% |
| Neuroone Medical Technologies Corp | $9.5m | 42.8% | 94.9% |
Compare with peers
- Beyond Air, Inc. revenue
- Anbio Biotechnology revenue
- Nuwellis, Inc. revenue
- Milestone Scientific Inc. revenue
- Neuroone Medical Technologies Corp revenue
Head to head: IVF vs XAIRIVF vs NNNNIVF vs NUWE
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies